Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Sinovac Rabies Vaccine (Serum-free Vero Cell) in Healthy Adults
NCT07055880Phase 2Not yet recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Rabies Vaccine (Serum-free Vero Cell) in rabies, sponsored by Sinovac Biotech Ltd.. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
Rabies Vaccine (Serum-free Vero Cell)
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07055880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07055880.